Cargando…
VGF: a biomarker and potential target for the treatment of neuropathic pain?
Neuropathic pain (NP) remains an area of considerable unmet medical need. A persistent challenge in the management of NP is to target the specific mechanisms leading to a change from normal to abnormal sensory perception while ensuring that the defensive pain perception remains intact. Targeting VGF...
Autores principales: | Soliman, Nadia, Okuse, Kenji, Rice, Andrew S.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882576/ https://www.ncbi.nlm.nih.gov/pubmed/31875189 http://dx.doi.org/10.1097/PR9.0000000000000786 |
Ejemplares similares
-
Neuropathic pain in leprosy: symptom profile characterization and comparison with neuropathic pain of other etiologies
por: Raicher, Irina, et al.
Publicado: (2018) -
Neuropathic pain drives anxiety behavior in mice, results consistent with anxiety levels in diabetic neuropathy patients
por: Sieberg, Christine B., et al.
Publicado: (2018) -
Role of hyperpolarization-activated cyclic nucleotide-gated ion channels in neuropathic pain: a proof-of-concept study of ivabradine in patients with chronic peripheral neuropathic pain
por: Bernard Healey, Shannon A., et al.
Publicado: (2021) -
Epidemiology of neuropathic pain: an analysis of prevalence and associated factors in UK Biobank
por: Baskozos, Georgios, et al.
Publicado: (2023) -
Sensitized vasoactive C-nociceptors: key fibers in peripheral neuropathic pain
por: Forstenpointner, Julia, et al.
Publicado: (2019)